Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jun;70(6):e30289.
doi: 10.1002/pbc.30289. Epub 2023 Apr 3.

Optimising urinary catecholamine metabolite diagnostics for neuroblastoma

Yvette A H Matser  1   2 , Iedan R N Verly  1   2 , Maria van der Ham  3 , Monique G M de Sain-van der Velden  3 , Nanda M Verhoeven-Duif  3 , Shifra Ash  4 , Giuliana Cangemi  5 , Sebastiano Barco  5 , Maja Beck Popovic  6 , André B P van Kuilenburg  2   7 , Godelieve A M Tytgat  1 ; SIOPEN Catecholamine Working Group
Collaborators, Affiliations

Optimising urinary catecholamine metabolite diagnostics for neuroblastoma

Yvette A H Matser et al. Pediatr Blood Cancer. 2023 Jun.

Abstract

Introduction: The analysis of urinary catecholamine metabolites is a cornerstone of neuroblastoma diagnostics. Currently, there is no consensus regarding the sampling method, and variable combinations of catecholamine metabolites are being used. We investigated if spot urine samples can be reliably used for analysis of a panel of catecholamine metabolites for the diagnosis of neuroblastoma.

Methods: Twenty-four-hour urine or spot urine samples were collected from patients with and without neuroblastoma at diagnosis. Homovanillic acid (HVA), vanillylmandelic acid (VMA), dopamine, 3-methoxytyramine, norepinephrine, normetanephrine, epinephrine and metanephrine were measured by high-performance liquid chromatography coupled with fluorescence detection (HPLC-FD) and/or ultra-performance liquid chromatography coupled with electrospray tandem mass spectrometry (UPLC-MS/MS).

Results: Catecholamine metabolite levels were measured in urine samples of 400 neuroblastoma patients (24-hour urine, n = 234; spot urine, n = 166) and 571 controls (all spot urine). Excretion levels of catecholamine metabolites and the diagnostic sensitivity for each metabolite were similar in 24-hour urine and spot urine samples (p > .08 and >.27 for all metabolites). The area under the receiver-operating-characteristic curve (AUC) of the panel containing all eight catecholamine metabolites was significantly higher compared to that of only HVA and VMA (AUC = 0.952 vs. 0.920, p = .02). No differences were observed in metabolite levels between the two analysis methods.

Conclusion: Catecholamine metabolites in spot urine and 24-hour urine resulted in similar diagnostic sensitivities. The Catecholamine Working Group recommends the implementation of spot urine as standard of care. The panel of eight catecholamine metabolites has superior diagnostic accuracy over VMA and HVA.

Keywords: catecholamine metabolites; diagnostic sensitivity; metanephrines; neuroblastoma; tandem mass spectrometry; urine collection.

PubMed Disclaimer

References

REFERENCES

    1. London WB, Castleberry RP, Matthay KK, et al. Evidence for an age cutoff greater than 365 days for neuroblastoma risk group stratification in the Children's Oncology Group. J Clin Oncol. 2005;23(27):6459-6465.
    1. Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022;72(1):7-33.
    1. Verly IR, van Kuilenburg AB, Abeling NG, et al. Catecholamines profiles at diagnosis: Increased diagnostic sensitivity and correlation with biological and clinical features in neuroblastoma patients. Eur J Cancer. 2017;72:235-243.
    1. Brodeur GM, Pritchard J, Berthold F, et al. Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J Clin Oncol. 1993;11(8):1466-1477.
    1. Fibiger W, Singer G, Miller AJ, Armstrong S, Datar M. Cortisol and catecholamines changes as functions of time-of-day and self-reported mood. Neurosci Biobehav Rev. 1984;8(4):523-530.

Publication types

LinkOut - more resources